"J Liver Cancer"[jour] - Search Results

Year	Number of Results
2020	24
2021	24
2022	28
2023	36
2024	39
2025	15

1

Identification of new biomarkers of hepatic cancer stem cells through proteomic profiling.

Choi SH, Lee HY, Yun SH, Jang SJ, Kim SU, Park JY, Ahn SH, Kim DY. Choi SH, et al. J Liver Cancer. 2025 Mar;25(1):123-133. doi: 10.17998/jlc.2025.03.08. Epub 2025 Mar 20. J Liver Cancer. 2025. PMID: 40108769 Free PMC article.

2

Management of hepatocellular carcinoma in elderly and adolescent/young adult populations.

Lee HA. Lee HA. J Liver Cancer. 2025 Mar;25(1):52-66. doi: 10.17998/jlc.2025.02.28. Epub 2025 Mar 20. J Liver Cancer. 2025. PMID: 40108768 Free PMC article.

3

Antitumor role of L-arginine and argininosuccinate synthetase 1 in hepatocellular carcinoma: direct and immunological mechanisms.

Eun HS. Eun HS. J Liver Cancer. 2025 Mar;25(1):1-3. doi: 10.17998/jlc.2025.03.07. Epub 2025 Mar 11. J Liver Cancer. 2025. PMID: 40065673 Free PMC article. No abstract available.

4

Insights into hepatocellular adenomas in Asia: molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risks.

Heo S, Song IH, Reizine E, Ronot M, Nault JC, Kim HY, Choi SH, Kim SY. Heo S, et al. J Liver Cancer. 2025 Mar;25(1):67-78. doi: 10.17998/jlc.2025.03.06. Epub 2025 Mar 7. J Liver Cancer. 2025. PMID: 40059521 Free PMC article.

5

Epidemiology and genomic features of biliary tract cancer and its unique features in Korea.

Woo S, Kim Y, Hwang S, Chon HJ. Woo S, et al. J Liver Cancer. 2025 Mar;25(1):41-51. doi: 10.17998/jlc.2025.02.27. Epub 2025 Mar 4. J Liver Cancer. 2025. PMID: 40033637 Free PMC article.

6

Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry.

An J, Chang Y, Choi GH, Sohn W, Song JE, Shin H, Yoon JH, Yoon JS, Jang HY, Cho EJ, Han JW, Hong SK, Cho JY, Jung KW, Park EH, Kim E, Kim BH. An J, et al. J Liver Cancer. 2025 Mar;25(1):109-122. doi: 10.17998/jlc.2025.02.20. Epub 2025 Mar 4. J Liver Cancer. 2025. PMID: 40033636 Free PMC article.

7

Correspondence to editorial on "Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea".

Han JW, Kim BH. Han JW, et al. J Liver Cancer. 2025 Mar;25(1):7-8. doi: 10.17998/jlc.2025.02.17. Epub 2025 Feb 27. J Liver Cancer. 2025. PMID: 40013317 Free PMC article. No abstract available.

8

Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance.

Lee DH. Lee DH. J Liver Cancer. 2025 Mar;25(1):31-40. doi: 10.17998/jlc.2025.02.16. Epub 2025 Feb 26. J Liver Cancer. 2025. PMID: 40007309 Free PMC article.

9

A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024.

Shin H, Yu SJ. Shin H, et al. J Liver Cancer. 2025 Mar;25(1):19-30. doi: 10.17998/jlc.2025.02.03. Epub 2025 Feb 10. J Liver Cancer. 2025. PMID: 39925090 Free PMC article.

10

Enhanced radiofrequency ablation for recurrent hepatocellular carcinoma post-transarterial chemoembolization: a prospective study utilizing twin internally cooled-perfusion electrodes.

Hwang S, Kim JH, Park SJ, Yu SJ, Kim YJ, Yoon JH, Lee JM. Hwang S, et al. J Liver Cancer. 2025 Mar;25(1):91-98. doi: 10.17998/jlc.2025.01.25. Epub 2025 Feb 7. J Liver Cancer. 2025. PMID: 39923764 Free PMC article.

11

Microwave ablation vs. liver resection for patients with hepatocellular carcinomas.

Gu H, Seo Y, Chung DJ, Paik KY, Yoon SK, Lim J. Gu H, et al. J Liver Cancer. 2025 Mar;25(1):99-108. doi: 10.17998/jlc.2025.02.02. Epub 2025 Feb 7. J Liver Cancer. 2025. PMID: 39914826 Free PMC article.

12

Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma.

Kim JS, Choi WM, Kim HI, Chung SW, Choi J, Lee D, Kim KM. Kim JS, et al. J Liver Cancer. 2025 Mar;25(1):79-90. doi: 10.17998/jlc.2024.12.27. Epub 2025 Jan 14. J Liver Cancer. 2025. PMID: 39806913 Free PMC article.

13

Molecular and immune landscape of hepatocellular carcinoma for therapeutic development.

Suzuki H, Mishra S, Paul S, Hoshida Y. Suzuki H, et al. J Liver Cancer. 2025 Mar;25(1):9-18. doi: 10.17998/jlc.2024.12.02. Epub 2024 Dec 6. J Liver Cancer. 2025. PMID: 39639434 Free PMC article.

14

Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea.

Hwang SY, Yang JD. Hwang SY, et al. J Liver Cancer. 2025 Mar;25(1):4-6. doi: 10.17998/jlc.2024.12.04. Epub 2024 Dec 5. J Liver Cancer. 2025. PMID: 39632454 Free PMC article. No abstract available.

15

Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report.

Kumar P, Krishna P, Maidur R, Chandrashekhar N, Raghavaiah S. Kumar P, et al. J Liver Cancer. 2025 Mar;25(1):134-137. doi: 10.17998/jlc.2024.09.26. Epub 2024 Nov 5. J Liver Cancer. 2025. PMID: 39506349 Free PMC article.

16

Practical consensus multi-specialty guidelines on image-guided ablation for hepatocellular carcinoma.

Lu DS. Lu DS. J Liver Cancer. 2024 Sep;24(2):120-123. doi: 10.17998/jlc.2024.09.11. Epub 2024 Sep 27. J Liver Cancer. 2024. PMID: 39362651 Free PMC article. No abstract available.

17

Multidisciplinary approaches to downstaging hepatocellular carcinoma: present and future.

Hwang SY, Choi H, Jeon W, Kim RG. Hwang SY, et al. J Liver Cancer. 2024 Sep;24(2):171-177. doi: 10.17998/jlc.2024.08.30. Epub 2024 Sep 5. J Liver Cancer. 2024. PMID: 39267270 Free PMC article.

18

Congratulatory remarks.

Kim KS. Kim KS. J Liver Cancer. 2024 Sep;24(2):119. doi: 10.17998/jlc.2024.09.10. Epub 2024 Sep 13. J Liver Cancer. 2024. PMID: 39267202 Free PMC article. No abstract available.

19

Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association.

Han S, Sung PS, Park SY, Kim JW, Hong HP, Yoon JH, Chung DJ, Kwon JH, Lim S, Kim JH, Shin SK, Kim TH, Lee DH, Choi JY; Research Committee of the Korean Liver Cancer Association. Han S, et al. J Liver Cancer. 2024 Sep;24(2):131-144. doi: 10.17998/jlc.2024.08.04. Epub 2024 Aug 30. J Liver Cancer. 2024. PMID: 39210668 Free PMC article.

20

The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases.

Kim BK. Kim BK. J Liver Cancer. 2024 Sep;24(2):129-130. doi: 10.17998/jlc.2024.08.26. Epub 2024 Aug 29. J Liver Cancer. 2024. PMID: 39198015 Free PMC article. No abstract available.

21

Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma.

Oh JH, Sinn DH. Oh JH, et al. J Liver Cancer. 2024 Sep;24(2):126-128. doi: 10.17998/jlc.2024.08.08. Epub 2024 Aug 16. J Liver Cancer. 2024. PMID: 39188209 Free PMC article. No abstract available.

22

Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study.

Han JW, Sohn W, Choi GH, Jang JW, Seo GH, Kim BH, Choi JY. Han JW, et al. J Liver Cancer. 2024 Sep;24(2):274-285. doi: 10.17998/jlc.2024.08.13. Epub 2024 Aug 26. J Liver Cancer. 2024. PMID: 39187270 Free PMC article.

23

Inter-reader agreement for LR-M imaging features: a premise for better imaging-based diagnosis in liver imaging.

Shin J. Shin J. J Liver Cancer. 2024 Sep;24(2):124-125. doi: 10.17998/jlc.2024.08.06. Epub 2024 Aug 13. J Liver Cancer. 2024. PMID: 39134467 Free PMC article. No abstract available.

24

New systemic treatment options for advanced cholangiocarcinoma.

Zanuso V, Tesini G, Valenzi E, Rimassa L. Zanuso V, et al. J Liver Cancer. 2024 Sep;24(2):155-170. doi: 10.17998/jlc.2024.08.07. Epub 2024 Aug 8. J Liver Cancer. 2024. PMID: 39113642 Free PMC article.

25

Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma.

Mak LY. Mak LY. J Liver Cancer. 2024 Sep;24(2):145-154. doi: 10.17998/jlc.2024.08.03. Epub 2024 Aug 5. J Liver Cancer. 2024. PMID: 39099070 Free PMC article.

26

Recent update of proton beam therapy for hepatocellular carcinoma: a systematic review and meta-analysis.

Bae SH, Jang WI, Mortensen HR, Weber B, Kim MS, Høyer M. Bae SH, et al. J Liver Cancer. 2024 Sep;24(2):286-302. doi: 10.17998/jlc.2024.06.26. Epub 2024 Jul 4. J Liver Cancer. 2024. PMID: 38961722 Free PMC article.

27

Assessment of real-time US-CT/MR-guided percutaneous gold fiducial marker implementation in malignant hepatic tumors for stereotactic body radiation therapy.

Hwang S, Chun SJ, Chie EK, Lee JM. Hwang S, et al. J Liver Cancer. 2024 Sep;24(2):263-273. doi: 10.17998/jlc.2024.06.03. Epub 2024 Jun 10. J Liver Cancer. 2024. PMID: 38853440 Free PMC article.

28

Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment.

Lee J, Choi JY, Lee SK. Lee J, et al. J Liver Cancer. 2024 Sep;24(2):253-262. doi: 10.17998/jlc.2024.06.02. Epub 2024 Jun 7. J Liver Cancer. 2024. PMID: 38852989 Free PMC article.

29

Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma.

Febro RJD, Perillo ESS, Kimura AA, Wong SN. Febro RJD, et al. J Liver Cancer. 2024 Sep;24(2):234-242. doi: 10.17998/jlc.2024.05.23. Epub 2024 Jun 3. J Liver Cancer. 2024. PMID: 38825875 Free PMC article.

30

Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy.

Song BG, Goh MJ, Kang W, Sinn DH, Gwak GY, Paik YH, Lee JH, Choi MS. Song BG, et al. J Liver Cancer. 2024 Sep;24(2):243-252. doi: 10.17998/jlc.2024.05.26. Epub 2024 Jun 3. J Liver Cancer. 2024. PMID: 38825874 Free PMC article.

31

Downstaging with atezolizumab-bevacizumab: a case series.

Kulkarni AV, Kumaraswamy P, Menon B, Sekaran A, Rambhatla A, Iyengar S, Alla M, Venishetty S, Ramachandra SK, Premkumar GV, Sharma M, Rao PN, Reddy DN, Singal AG. Kulkarni AV, et al. J Liver Cancer. 2024 Sep;24(2):224-233. doi: 10.17998/jlc.2024.05.12. Epub 2024 May 27. J Liver Cancer. 2024. PMID: 38797993 Free PMC article.

32

Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis.

Lee JH, Kim KY, Lee CH, Kim M, Yoon CJ. Lee JH, et al. J Liver Cancer. 2024 Sep;24(2):217-223. doi: 10.17998/jlc.2024.05.08. Epub 2024 May 14. J Liver Cancer. 2024. PMID: 38741422 Free PMC article.

33

Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging.

Bae JS, Lee JM, Hur BY, Yoo J, Park SJ. Bae JS, et al. J Liver Cancer. 2024 Sep;24(2):206-216. doi: 10.17998/jlc.2024.05.01. Epub 2024 May 8. J Liver Cancer. 2024. PMID: 38714358 Free PMC article.

34

Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis.

Kim DH, Choi SH. Kim DH, et al. J Liver Cancer. 2024 Sep;24(2):192-205. doi: 10.17998/jlc.2024.04.05. Epub 2024 Apr 15. J Liver Cancer. 2024. PMID: 38616543 Free PMC article.

35

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma.

Yang J, Choi WM, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Moon DB, Jung DH, Choi J. Yang J, et al. J Liver Cancer. 2024 Sep;24(2):178-191. doi: 10.17998/jlc.2024.03.25. Epub 2024 Apr 3. J Liver Cancer. 2024. PMID: 38566326 Free PMC article.

36

Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database.

Kim BH, Yun EH, Lee JH, Hong G, Park JY, Shim JH, Kim E, Kong HJ, Jung KW, Lim YS. Kim BH, et al. J Liver Cancer. 2024 Mar;24(1):57-61. doi: 10.17998/jlc.2024.03.03. Epub 2024 Mar 26. J Liver Cancer. 2024. PMID: 38528809 Free PMC article.

37

Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives.

Oh JH, Sinn DH. Oh JH, et al. J Liver Cancer. 2024 Mar;24(1):47-56. doi: 10.17998/jlc.2024.02.27. Epub 2024 Mar 25. J Liver Cancer. 2024. PMID: 38527905 Free PMC article.

38

Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review.

Kim D, Kim JS. Kim D, et al. J Liver Cancer. 2024 Mar;24(1):33-46. doi: 10.17998/jlc.2024.02.26. Epub 2024 Mar 25. J Liver Cancer. 2024. PMID: 38523467 Free PMC article.

39

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.

Kim DY. Kim DY. J Liver Cancer. 2024 Mar;24(1):62-70. doi: 10.17998/jlc.2024.03.13. Epub 2024 Mar 25. J Liver Cancer. 2024. PMID: 38523466 Free PMC article.

40

Radiofrequency for hepatocellular carcinoma larger than 3 cm: potential for applications in daily practice.

Kim JH, Sung PS. Kim JH, et al. J Liver Cancer. 2024 Mar;24(1):1-2. doi: 10.17998/jlc.2024.02.13. Epub 2024 Mar 14. J Liver Cancer. 2024. PMID: 38481357 Free PMC article. No abstract available.

41

Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?

Stefanini B, Ielasi L, Pallotta DP, Penazza S, Marseglia M, Piscaglia F. Stefanini B, et al. J Liver Cancer. 2024 Mar;24(1):23-32. doi: 10.17998/jlc.2024.02.21. Epub 2024 Mar 12. J Liver Cancer. 2024. PMID: 38468499 Free PMC article.

42

Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis.

Lim M, Kim J, Rhu J, Choi GS, Joh JW. Lim M, et al. J Liver Cancer. 2024 Mar;24(1):102-112. doi: 10.17998/jlc.2024.01.31. Epub 2024 Feb 14. J Liver Cancer. 2024. PMID: 38351676 Free PMC article.

43

Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy.

Kim NR, Rho SY, Navarro J, An C, Han DH, Choi JS, Kim MJ, Choi GH. Kim NR, et al. J Liver Cancer. 2024 Mar;24(1):92-101. doi: 10.17998/jlc.2024.01.25. Epub 2024 Feb 14. J Liver Cancer. 2024. PMID: 38351675 Free PMC article.

44

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis.

Park J, Lee YB, Ko Y, Park Y, Shin H, Hur MH, Park MK, Lee DW, Cho EJ, Lee KH, Lee JH, Yu SJ, Kim TY, Kim YJ, Kim TY, Yoon JH. Park J, et al. J Liver Cancer. 2024 Mar;24(1):81-91. doi: 10.17998/jlc.2023.12.25. Epub 2024 Jan 19. J Liver Cancer. 2024. PMID: 38246747 Free PMC article.

45

Reply to the Letter regarding "Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study".

Nouso K, Kariyama K. Nouso K, et al. J Liver Cancer. 2024 Mar;24(1):5-6. doi: 10.17998/jlc.2024.01.02. Epub 2024 Jan 19. J Liver Cancer. 2024. PMID: 38246746 Free PMC article. No abstract available.

46

Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist.

Komuta M. Komuta M. J Liver Cancer. 2024 Mar;24(1):17-22. doi: 10.17998/jlc.2023.12.11. Epub 2024 Jan 3. J Liver Cancer. 2024. PMID: 38171533 Free PMC article.

47

Letter regarding "Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study".

Kim J. Kim J. J Liver Cancer. 2024 Mar;24(1):3-4. doi: 10.17998/jlc.2023.12.04. Epub 2023 Dec 12. J Liver Cancer. 2024. PMID: 38097195 Free PMC article. No abstract available.

48

Complications of immunotherapy in advanced hepatocellular carcinoma.

Song YG, Yoo JJ, Kim SG, Kim YS. Song YG, et al. J Liver Cancer. 2024 Mar;24(1):9-16. doi: 10.17998/jlc.2023.11.21. Epub 2023 Nov 29. J Liver Cancer. 2024. PMID: 38018074 Free PMC article.

49

Metastatic papillary renal cell carcinoma with portal vein tumor thrombosis confirmed on blind liver biopsy.

Kim H, Roh TH, Lee JS, Kim MS, Kim BK. Kim H, et al. J Liver Cancer. 2024 Mar;24(1):113-117. doi: 10.17998/jlc.2023.11.05. Epub 2023 Nov 29. J Liver Cancer. 2024. PMID: 38017367 Free PMC article.

50

Performance of HCC diagnosis in the KLCA-NCC guidelines: a closer look at MRI contrast agents and HCC imaging hallmarks.

Min JH, Kim YK. Min JH, et al. J Liver Cancer. 2024 Mar;24(1):7-8. doi: 10.17998/jlc.2023.10.08. Epub 2023 Nov 6. J Liver Cancer. 2024. PMID: 37927042 Free PMC article. No abstract available.

51

Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study.

Kariyama K, Nouso K, Hiraoka A, Toyoda H, Tada T, Tsuji K, Ishikawa T, Hatanaka T, Itobayashi E, Takaguchi K, Tsutsui A, Naganuma A, Yasuda S, Kakizaki S, Wakuta A, Shiota S, Kudo M, Kumada T. Kariyama K, et al. J Liver Cancer. 2024 Mar;24(1):71-80. doi: 10.17998/jlc.2023.09.11. Epub 2023 Nov 6. J Liver Cancer. 2024. PMID: 37927041 Free PMC article.

52

A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma.

Lee YR. Lee YR. J Liver Cancer. 2023 Sep;23(2):316-329. doi: 10.17998/jlc.2023.09.04. Epub 2023 Sep 22. J Liver Cancer. 2023. PMID: 37743048 Free PMC article.

53

Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes.

Yoon JH, Choi SK. Yoon JH, et al. J Liver Cancer. 2023 Sep;23(2):300-315. doi: 10.17998/jlc.2023.08.27. Epub 2023 Sep 21. J Liver Cancer. 2023. PMID: 37734717 Free PMC article.

54

Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings.

Lee SW, Kang MK, Zhang X. Lee SW, et al. J Liver Cancer. 2023 Sep;23(2):238-240. doi: 10.17998/jlc.2023.09.12. Epub 2023 Sep 20. J Liver Cancer. 2023. PMID: 37726895 Free PMC article. No abstract available.

55

Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review.

Jeong WK. Jeong WK. J Liver Cancer. 2023 Sep;23(2):272-283. doi: 10.17998/jlc.2023.08.25. Epub 2023 Sep 19. J Liver Cancer. 2023. PMID: 37723641 Free PMC article.

56

Clinical outcome of surgical resection for multifocal T2-T3 hepatocellular carcinoma up to 3 nodules: a comparative analysis with a single nodule.

Yu S, Jo HS, Yu YD, Choi YJ, Kim DS. Yu S, et al. J Liver Cancer. 2023 Sep;23(2):377-388. doi: 10.17998/jlc.2023.08.24. Epub 2023 Sep 15. J Liver Cancer. 2023. PMID: 37718473 Free PMC article.

57

Imaging prognostication and tumor biology in hepatocellular carcinoma.

Kadi D, Yamamoto MF, Lerner EC, Jiang H, Fowler KJ, Bashir MR. Kadi D, et al. J Liver Cancer. 2023 Sep;23(2):284-299. doi: 10.17998/jlc.2023.08.29. Epub 2023 Sep 15. J Liver Cancer. 2023. PMID: 37710379 Free PMC article.

58

The efficacy of treatment for hepatocellular carcinoma in elderly patients.

Lee HA, Lee S, Lee HL, Song JE, Lee DH, Han S, Shim JH, Kim BH, Choi JY, Rhim H, Kim DY. Lee HA, et al. J Liver Cancer. 2023 Sep;23(2):362-376. doi: 10.17998/jlc.2023.08.03. Epub 2023 Sep 14. J Liver Cancer. 2023. PMID: 37705145 Free PMC article.

59

Letter regarding "Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab".

Bae SH, Park HC. Bae SH, et al. J Liver Cancer. 2023 Sep;23(2):402-404. doi: 10.17998/jlc.2023.08.18. Epub 2023 Sep 8. J Liver Cancer. 2023. PMID: 37680020 Free PMC article. No abstract available.

60

A single hepatic mass with two tales: hepatic tuberculosis and hepatocellular carcinoma.

Koh YI, Leow WQ. Koh YI, et al. J Liver Cancer. 2023 Sep;23(2):397-401. doi: 10.17998/jlc.2023.08.30. Epub 2023 Sep 8. J Liver Cancer. 2023. PMID: 37680019 Free PMC article.

61

Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice.

Kim N, Yu JI, Park HC, Hong JY, Lim HY, Goh MJ, Paik YH. Kim N, et al. J Liver Cancer. 2023 Sep;23(2):350-361. doi: 10.17998/jlc.2023.08.10. Epub 2023 Sep 6. J Liver Cancer. 2023. PMID: 37670423 Free PMC article.

62

The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma.

Lee MMP, Chan LL, Chan SL. Lee MMP, et al. J Liver Cancer. 2023 Sep;23(2):262-271. doi: 10.17998/jlc.2023.07.17. Epub 2023 Aug 17. J Liver Cancer. 2023. PMID: 37589044 Free PMC article.

63

Hepatic basidiobolomycosis masquerading as cholangiocarcinoma: a case report and literature review.

Sehrawat R, Bansal N, Srivastava A, Malik D, Vij V. Sehrawat R, et al. J Liver Cancer. 2023 Sep;23(2):389-396. doi: 10.17998/jlc.2023.06.07. Epub 2023 Aug 17. J Liver Cancer. 2023. PMID: 37587037 Free PMC article.

64

Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Kim TH, Kim BH, Cho YR, Koh YH, Park JW. Kim TH, et al. J Liver Cancer. 2023 Sep;23(2):330-340. doi: 10.17998/jlc.2023.04.14. Epub 2023 May 16. J Liver Cancer. 2023. PMID: 37488926 Free PMC article.

65

Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma.

Mun K, Han J, Roh P, Park J, Kim G, Hur W, Jang J, Choi J, Yoon S, You Y, Choi H, Sung P. Mun K, et al. J Liver Cancer. 2023 Sep;23(2):341-349. doi: 10.17998/jlc.2023.04.30. Epub 2023 Jun 12. J Liver Cancer. 2023. PMID: 37488925 Free PMC article.

66

Implications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinoma.

Chung JW. Chung JW. J Liver Cancer. 2023 Sep;23(2):235-237. doi: 10.17998/jlc.2023.06.29. Epub 2023 Jul 25. J Liver Cancer. 2023. PMID: 37488924 Free PMC article. No abstract available.

67

Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association.

Cho Y, Choi JW, Kwon H, Kim KY, Lee BC, Chu HH, Lee DH, Lee HA, Kim GM, Oh JS, Hyun D, Lee IJ, Rhim H; Research Committee of the Korean Liver Cancer Association. Cho Y, et al. J Liver Cancer. 2023 Sep;23(2):241-261. doi: 10.17998/jlc.2023.05.22. Epub 2023 Jul 14. J Liver Cancer. 2023. PMID: 37449302 Free PMC article.

68

The development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case report.

Na SK, Kang SH. Na SK, et al. J Liver Cancer. 2023 Mar;23(1):230-234. doi: 10.17998/jlc.2023.03.03. Epub 2023 Mar 27. J Liver Cancer. 2023. PMID: 37384034 Free PMC article.

69

Adult hepatoblastoma: making the challenging distinction from hepatocellular carcinoma.

Pagarigan AKL, Mendoza PGL. Pagarigan AKL, et al. J Liver Cancer. 2023 Mar;23(1):219-224. doi: 10.17998/jlc.2023.02.24. Epub 2023 Mar 13. J Liver Cancer. 2023. PMID: 37384033 Free PMC article.

70

Non-alcoholic fatty liver disease-related hepatocellular carcinoma.

Daher D, Dahan KSE, Singal AG. Daher D, et al. J Liver Cancer. 2023 Mar;23(1):127-142. doi: 10.17998/jlc.2022.12.30. Epub 2023 Feb 9. J Liver Cancer. 2023. PMID: 37384032 Free PMC article. Review.

71

How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion.

Kim BK. Kim BK. J Liver Cancer. 2023 Mar;23(1):121-123. doi: 10.17998/jlc.2023.3.10. Epub 2023 Mar 24. J Liver Cancer. 2023. PMID: 37384031 Free PMC article. No abstract available.

72

Radiologic features of hepatocellular carcinoma related to prognosis.

Hwang SH, Rhee H. Hwang SH, et al. J Liver Cancer. 2023 Mar;23(1):143-156. doi: 10.17998/jlc.2023.02.16. Epub 2023 Mar 9. J Liver Cancer. 2023. PMID: 37384030 Free PMC article. Review.

73

Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah's witness: a case report.

Ratnayake S, Subasinghe D, Dassanayake V, Sivaganesh S. Ratnayake S, et al. J Liver Cancer. 2023 Mar;23(1):202-205. doi: 10.17998/jlc.2023.01.27. Epub 2023 Feb 15. J Liver Cancer. 2023. PMID: 37384029 Free PMC article.

74

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study.

Yu SJ, Lee YB, Cho EJ, Lee JH, Kim HC, Chung JW, Yoon JH, Kim YJ. Yu SJ, et al. J Liver Cancer. 2023 Mar;23(1):166-176. doi: 10.17998/jlc.2023.02.08. Epub 2023 Mar 3. J Liver Cancer. 2023. PMID: 37384028 Free PMC article.

75

A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment.

Cho Y, Kim BH, Kim TH, Koh YH, Park JW. Cho Y, et al. J Liver Cancer. 2023 Mar;23(1):206-212. doi: 10.17998/jlc.2023.02.09. Epub 2023 Feb 24. J Liver Cancer. 2023. PMID: 37384027 Free PMC article.

76

Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria.

Yoon JK, Lee S, Hwang JA, Lee JE, Kim SS, Kim MJ. Yoon JK, et al. J Liver Cancer. 2023 Mar;23(1):157-165. doi: 10.17998/jlc.2023.02.07. Epub 2023 Feb 23. J Liver Cancer. 2023. PMID: 37384026 Free PMC article.

77

Impact of the updated KLCA-NCC criteria for diagnosis of "probable HCC" in liver MRI: comparisons between KLCA v2022 and v2018.

Yoon JH. Yoon JH. J Liver Cancer. 2023 Mar;23(1):124-126. doi: 10.17998/jlc.2023.3.7. Epub 2023 Mar 21. J Liver Cancer. 2023. PMID: 37384025 Free PMC article. No abstract available.

78

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.

Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea. J Liver Cancer. 2023 Mar;23(1):1-120. doi: 10.17998/jlc.2022.11.07. Epub 2022 Dec 9. J Liver Cancer. 2023. PMID: 37384024 Free PMC article. Review.

79

A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab.

Kim HJ, Hwang SY, Im JW, Jeon KJ, Jeon W. Kim HJ, et al. J Liver Cancer. 2023 Mar;23(1):213-218. doi: 10.17998/jlc.2023.02.23. Epub 2023 Mar 9. J Liver Cancer. 2023. PMID: 37384023 Free PMC article.

80

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment.

Jin S, Choi WM, Shim JH, Lee D, Kim KM, Lim YS, Lee HC, Jung J, Yoon SM, Choi J. Jin S, et al. J Liver Cancer. 2023 Mar;23(1):177-188. doi: 10.17998/jlc.2023.03.04. Epub 2023 Mar 23. J Liver Cancer. 2023. PMID: 37384022 Free PMC article.

81

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab.

Kim YT, Kim J, Seong J. Kim YT, et al. J Liver Cancer. 2023 Mar;23(1):225-229. doi: 10.17998/jlc.2023.02.27. Epub 2023 Mar 16. J Liver Cancer. 2023. PMID: 37384021 Free PMC article.

82

Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study.

Yoo SH, Kim SS, Kim SG, Kwon JH, Lee HA, Seo YS, Jung YK, Yim HJ, Song DS, Kang SH, Kim MY, Ahn YH, Han J, Kim YS, Chang Y, Jeong SW, Jang JY, Yoo JJ. Yoo SH, et al. J Liver Cancer. 2023 Mar;23(1):189-201. doi: 10.17998/jlc.2023.03.11. Epub 2023 Mar 24. J Liver Cancer. 2023. PMID: 37384020 Free PMC article.

83

Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report.

Na SK. Na SK. J Liver Cancer. 2022 Sep;22(2):178-182. doi: 10.17998/jlc.2022.06.10. Epub 2022 Jun 22. J Liver Cancer. 2022. PMID: 37383417 Free PMC article.

84

Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report.

Kim S, Kim JH, Han JW, Jang JW, Choi JY, Yoon SK, Sung PS. Kim S, et al. J Liver Cancer. 2022 Sep;22(2):202-206. doi: 10.17998/jlc.2022.09.17. Epub 2022 Sep 20. J Liver Cancer. 2022. PMID: 37383416 Free PMC article.

85

Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology.

Jang W, Lee HW, Lee JS, Kim BK, Kim SU, Park JY, Ahn SH, Kim DY. Jang W, et al. J Liver Cancer. 2022 Sep;22(2):158-166. doi: 10.17998/jlc.2022.09.18. Epub 2022 Sep 27. J Liver Cancer. 2022. PMID: 37383415 Free PMC article.

86

Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study.

Jang JY, Jung J, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Park JH, Yoon SM. Jang JY, et al. J Liver Cancer. 2022 Sep;22(2):136-145. doi: 10.17998/jlc.2022.08.18. Epub 2022 Sep 16. J Liver Cancer. 2022. PMID: 37383414 Free PMC article.

87

Yoon et al. Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry.

Lee JH. Lee JH. J Liver Cancer. 2022 Sep;22(2):207. doi: 10.17998/jlc.21.1.58.e1. Epub 2022 Jun 8. J Liver Cancer. 2022. PMID: 37383413 Free PMC article.

88

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment.

Ahn YH, Lee H, Han JE, Cho HJ, Cheong JY, Park B, Kim SS. Ahn YH, et al. J Liver Cancer. 2022 Sep;22(2):125-135. doi: 10.17998/jlc.2022.05.24. Epub 2022 Jun 28. J Liver Cancer. 2022. PMID: 37383412 Free PMC article.

89

Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report.

Chang SH, Kim TS, Jeon YH, Jung NH, Choi DH. Chang SH, et al. J Liver Cancer. 2022 Sep;22(2):183-187. doi: 10.17998/jlc.2022.08.03. Epub 2022 Aug 24. J Liver Cancer. 2022. PMID: 37383411 Free PMC article.

90

Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study.

Jo SJ, Rhu J, Kim JM, Choi GS, Joh JW. Jo SJ, et al. J Liver Cancer. 2022 Sep;22(2):146-157. doi: 10.17998/jlc.2022.08.22. Epub 2022 Sep 14. J Liver Cancer. 2022. PMID: 37383410 Free PMC article.

91

The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes.

Yoo JE, Nahm JH, Kim YJ, Jeon Y, Park YN. Yoo JE, et al. J Liver Cancer. 2022 Sep;22(2):115-124. doi: 10.17998/jlc.2022.04.20. Epub 2022 May 20. J Liver Cancer. 2022. PMID: 37383409 Free PMC article.

92

The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis.

Chang Y, Jeong SW, Jang JY, Eun H, Lee YS, Song DS, Yu SJ, Lee SH, Kim W, Lee HW, Kim SG, Ryu S, Park S. Chang Y, et al. J Liver Cancer. 2022 Sep;22(2):167-177. doi: 10.17998/jlc.2022.09.19. Epub 2022 Sep 29. J Liver Cancer. 2022. PMID: 37383408 Free PMC article.

93

Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report.

Hur MH, Kim H, Lee JH. Hur MH, et al. J Liver Cancer. 2022 Sep;22(2):188-193. doi: 10.17998/jlc.2022.08.17. Epub 2022 Aug 31. J Liver Cancer. 2022. PMID: 37383407 Free PMC article.

94

Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?

Lee HW. Lee HW. J Liver Cancer. 2022 Sep;22(2):91-92. doi: 10.17998/jlc.2022.09.20. Epub 2022 Sep 29. J Liver Cancer. 2022. PMID: 37383406 Free PMC article. No abstract available.

95

Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report.

Kim CH, Choi GH, Na HY, Yoon CJ, Cho JY, Jang S, Kim JH, Jang ES, Kim JW, Jeong SH. Kim CH, et al. J Liver Cancer. 2022 Sep;22(2):194-201. doi: 10.17998/jlc.2022.08.24. Epub 2022 Sep 15. J Liver Cancer. 2022. PMID: 37383405 Free PMC article.

96

Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma.

Kim DH. Kim DH. J Liver Cancer. 2022 Sep;22(2):93-102. doi: 10.17998/jlc.2022.03.28. Epub 2022 Apr 22. J Liver Cancer. 2022. PMID: 37383404 Free PMC article. Review.

97

Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma.

Choi EJ, Kim YJ. Choi EJ, et al. J Liver Cancer. 2022 Sep;22(2):103-114. doi: 10.17998/jlc.2022.09.08. Epub 2022 Sep 22. J Liver Cancer. 2022. PMID: 37383403 Free PMC article. Review.

98

Concurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report.

Park MK, Yu SJ. Park MK, et al. J Liver Cancer. 2022 Mar;22(1):69-74. doi: 10.17998/jlc.2022.03.09. Epub 2022 Mar 21. J Liver Cancer. 2022. PMID: 37383541 Free PMC article.

99

Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report.

Kim D, Park S, Sohn W, Hong HP, Kim BI. Kim D, et al. J Liver Cancer. 2022 Mar;22(1):51-56. doi: 10.17998/jlc.2021.12.28. Epub 2022 Jan 27. J Liver Cancer. 2022. PMID: 37383540 Free PMC article.

100

Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria.

Cho Y, Kim BH, Kim TH, Koh YH, Park JW. Cho Y, et al. J Liver Cancer. 2022 Mar;22(1):63-68. doi: 10.17998/jlc.2022.01.18. Epub 2022 Feb 14. J Liver Cancer. 2022. PMID: 37383539 Free PMC article.

101

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma.

An J, Kang HJ, Yu E, Lee HC, Shim JH. An J, et al. J Liver Cancer. 2022 Mar;22(1):40-50. doi: 10.17998/jlc.2022.03.06. Epub 2022 Mar 17. J Liver Cancer. 2022. PMID: 37383538 Free PMC article.

102

Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report.

Kim IJ, Yoo SH, Lee JI, Lee KS, Lee HW, Lim JH. Kim IJ, et al. J Liver Cancer. 2022 Mar;22(1):84-90. doi: 10.17998/jlc.2022.03.07. Epub 2022 Mar 22. J Liver Cancer. 2022. PMID: 37383537 Free PMC article.

103

Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma.

Lee A, Lee J, Yang H, Sung SY, Jeon CH, Kim SH, Choi MH, Lee YJ, Chun HJ, Bae SH. Lee A, et al. J Liver Cancer. 2022 Mar;22(1):75-83. doi: 10.17998/jlc.2022.03.04. Epub 2022 Mar 18. J Liver Cancer. 2022. PMID: 37383536 Free PMC article.

104

Recent updates on the classification of hepatoblastoma according to the International Pediatric Liver Tumors Consensus.

Jeong SU, Kang HJ. Jeong SU, et al. J Liver Cancer. 2022 Mar;22(1):23-29. doi: 10.17998/jlc.2022.02.24. Epub 2022 Mar 17. J Liver Cancer. 2022. PMID: 37383535 Free PMC article. Review.

105

Radioembolization for hepatocellular carcinoma: what clinicians need to know.

Choi JW, Kim HC. Choi JW, et al. J Liver Cancer. 2022 Mar;22(1):4-13. doi: 10.17998/jlc.2022.01.16. Epub 2022 Feb 23. J Liver Cancer. 2022. PMID: 37383534 Free PMC article. Review.

106

A case report of advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy and sorafenib combination therapy followed by metastasectomy of lung and muscle metastases.

Moon SY, Han SY, Baek YH. Moon SY, et al. J Liver Cancer. 2022 Mar;22(1):57-62. doi: 10.17998/jlc.2021.12.20. Epub 2022 Jan 6. J Liver Cancer. 2022. PMID: 37383533 Free PMC article.

107

Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma.

Jang JW, Kim JM, Kim HS, Kim JS, Han JW, Lee SK, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK. Jang JW, et al. J Liver Cancer. 2022 Mar;22(1):30-39. doi: 10.17998/jlc.2022.02.25. Epub 2022 Mar 21. J Liver Cancer. 2022. PMID: 37383532 Free PMC article.

108

A clinical and pathological update on hepatocellular carcinoma.

Renne SL, Di Tommaso L. Renne SL, et al. J Liver Cancer. 2022 Mar;22(1):14-22. doi: 10.17998/jlc.2022.03.18. Epub 2022 Mar 31. J Liver Cancer. 2022. PMID: 37383531 Free PMC article. Review.

109

Is multidisciplinary treatment effective for hepatocellular carcinoma with portal vein tumor thrombus?

Choe WH. Choe WH. J Liver Cancer. 2022 Mar;22(1):1-3. doi: 10.17998/jlc.2022.03.15. Epub 2022 Mar 31. J Liver Cancer. 2022. PMID: 37383530 Free PMC article. No abstract available.

110

Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report.

Hwang SY, Lee SM, Lim JW, Jeon GJ, Lee HW. Hwang SY, et al. J Liver Cancer. 2021 Sep;21(2):177-180. doi: 10.17998/jlc.2021.09.10. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383089 Free PMC article.

111

A case report of a patient presented with skin ulcer after treatment of lenvatinib.

Cha S, Kim DW, Choe JW, Kim TH, Kim SY, Hyun JJ, Jung SW, Koo JS, Jung YK, Yim HJ. Cha S, et al. J Liver Cancer. 2021 Sep;21(2):194-198. doi: 10.17998/jlc.2021.09.20. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383088 Free PMC article.

112

Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma.

Rim CH. Rim CH. J Liver Cancer. 2021 Sep;21(2):113-123. doi: 10.17998/jlc.2021.05.26. Epub 2021 Aug 11. J Liver Cancer. 2021. PMID: 37383087 Free PMC article. Review.

113

Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report.

Joo DJ, Kim DY, Seong J, Kim HJ, Lee JG, Han DH, Choi GH, Kim MS, Choi JS, Kim SI. Joo DJ, et al. J Liver Cancer. 2021 Sep;21(2):181-186. doi: 10.17998/jlc.2021.09.08. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383086 Free PMC article.

114

Advances in immune checkpoint inhibitors for hepatocellular carcinoma.

Han JW, Park SH. Han JW, et al. J Liver Cancer. 2021 Sep;21(2):139-145. doi: 10.17998/jlc.2021.09.24. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383085 Free PMC article. Review.

115

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial.

Kim TH, Kim NH, Kim JD, Kim YN, Kim YJ, Kim EJ, Yoo KD, Ryu CH, Song HH, Kim H. Kim TH, et al. J Liver Cancer. 2021 Sep;21(2):146-154. doi: 10.17998/jlc.2021.05.20. Epub 2021 Aug 11. J Liver Cancer. 2021. PMID: 37383084 Free PMC article.

116

Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report.

Lee BM, Seong J. Lee BM, et al. J Liver Cancer. 2021 Sep;21(2):163-168. doi: 10.17998/jlc.2021.08.06. Epub 2021 Sep 2. J Liver Cancer. 2021. PMID: 37383083 Free PMC article.

117

The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma.

Park JM, Choe WH, Kim JH, Kwon SY, Yoo BC. Park JM, et al. J Liver Cancer. 2021 Sep;21(2):155-162. doi: 10.17998/jlc.2021.09.22. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383082 Free PMC article.

118

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis.

Kim SJ, Kim JM. Kim SJ, et al. J Liver Cancer. 2021 Sep;21(2):105-112. doi: 10.17998/jlc.2021.03.17. Epub 2021 Sep 2. J Liver Cancer. 2021. PMID: 37383081 Free PMC article. Review.

119

Primary multifocal cystic signet ring neuroendocrine tumor of liver: a case report.

Bansal N, Satapathy B. Bansal N, et al. J Liver Cancer. 2021 Sep;21(2):187-193. doi: 10.17998/jlc.2021.09.17. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383080 Free PMC article.

120

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report.

Han JE, Cho HJ, Kim SS, Cheong JY. Han JE, et al. J Liver Cancer. 2021 Sep;21(2):169-176. doi: 10.17998/jlc.2021.08.26. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383079 Free PMC article.

121

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment.

Kim BH, Park JW. Kim BH, et al. J Liver Cancer. 2021 Sep;21(2):124-138. doi: 10.17998/jlc.2021.09.23. Epub 2021 Sep 30. J Liver Cancer. 2021. PMID: 37383078 Free PMC article. Review.

122

Hepatocellular Carcinoma Arising from Hepatocellular Adenoma in an Elderly Male Patient.

Lim M, Kim JM, Kwon JE, Jeong ES, Yang J, Lee O, Kim KD, Kim SJ, Rhu J, Choi GS, Joh JW. Lim M, et al. J Liver Cancer. 2021 Mar;21(1):87-91. doi: 10.17998/jlc.21.1.87. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384277 Free PMC article.

123

A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer.

Song JW, Chun HS, Lee JS, Lee HW, Kim BK, Kim SU, Park JY, Ahn SH, Park YN, Han DH, Kim DY. Song JW, et al. J Liver Cancer. 2021 Mar;21(1):69-75. doi: 10.17998/jlc.21.1.69. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384276 Free PMC article.

124

Huge Hepatic Angiomyolipoma Mimicking Low Grade Hepatocellular Carcinoma.

Hwang HS, Han DH. Hwang HS, et al. J Liver Cancer. 2021 Mar;21(1):76-80. doi: 10.17998/jlc.21.1.76. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384275 Free PMC article.

125

Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area.

Shin J, Yu JH, Jin YJ, Lee JW. Shin J, et al. J Liver Cancer. 2021 Mar;21(1):34-44. doi: 10.17998/jlc.21.1.34. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384274 Free PMC article.

126

Update on Pathologic and Radiologic Diagnosis of Combined Hepatocellular-Cholangiocarcinoma.

Rhee H, Park JH, Park YN. Rhee H, et al. J Liver Cancer. 2021 Mar;21(1):12-24. doi: 10.17998/jlc.21.1.12. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384273 Free PMC article. Review.

127

A Case of Metastatic Melanoma in the Liver Mimicking Hepatocellular Carcinoma.

So JK, Hong JY, Chung MW, Cho SB. So JK, et al. J Liver Cancer. 2021 Mar;21(1):92-96. doi: 10.17998/jlc.21.1.92. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384272 Free PMC article.

128

Rare Case of Pyogenic Brain Abscess after Transarterial Chemoembolization in a Patient with Hepatocellular Carcinoma: Case Report and Literature Review.

Myeong JH, Yoo JJ, Kim SG, Kim YS. Myeong JH, et al. J Liver Cancer. 2021 Mar;21(1):81-86. doi: 10.17998/jlc.21.1.81. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384271 Free PMC article.

129

Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma.

Moon H, Ro SW. Moon H, et al. J Liver Cancer. 2021 Mar;21(1):1-11. doi: 10.17998/jlc.21.1.1. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384270 Free PMC article. Review.

130

Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm.

Hwang S, Kim KH, Moon DB, Ahn CS, Ha TY, Song GW, Jung DH, Park GC. Hwang S, et al. J Liver Cancer. 2021 Mar;21(1):45-57. doi: 10.17998/jlc.21.1.45. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384269 Free PMC article.

131

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization.

Noh M, Kim BK, Kim SU. Noh M, et al. J Liver Cancer. 2021 Mar;21(1):97-103. doi: 10.17998/jlc.21.1.97. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384268 Free PMC article.

132

Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry.

Yoon JS, Lee HA, Kim HY, Sinn DH, Lee DH, Hong SK, Cho JY, Choi J, Chang Y, Kong HJ, Kim E, Won YJ, Lee JH. Yoon JS, et al. J Liver Cancer. 2021 Mar;21(1):58-68. doi: 10.17998/jlc.21.1.58. Epub 2021 Mar 31. J Liver Cancer. 2021. Retracted and republished in: J Liver Cancer. 2022 Sep;22(2):207. doi: 10.17998/jlc.21.1.58.e1. PMID: 37384267 Free PMC article. Retracted and republished.

133

External Beam Radiotherapy for Hepatocellular Carcinoma: a Review of the Current Guidelines in the East and the West.

Yoon SM. Yoon SM. J Liver Cancer. 2021 Mar;21(1):25-33. doi: 10.17998/jlc.21.1.25. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384266 Free PMC article. Review.

134

Long-term Survival of a Patient with a Large Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis and Spontaneous Tumor Rupture.

Lee HW, Kim GA, Oh CH, Shim JJ, Kim BH. Lee HW, et al. J Liver Cancer. 2020 Sep;20(2):148-153. doi: 10.17998/jlc.20.2.148. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384326 Free PMC article.

135

Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma.

Sung PS, Cho SW, Lee J, Yang H, Jang JW, Bae SH, Choi JY, Yoon SK. Sung PS, et al. J Liver Cancer. 2020 Sep;20(2):128-134. doi: 10.17998/jlc.20.2.128. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384325 Free PMC article.

136

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy.

Goh MJ, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. J Liver Cancer. 2020 Sep;20(2):160-166. doi: 10.17998/jlc.20.2.160. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384324 Free PMC article.

137

Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis.

Jo HH, Chun SJ, Yoo JJ, Lee MH, Kim SG, Kim YS. Jo HH, et al. J Liver Cancer. 2020 Sep;20(2):177-182. doi: 10.17998/jlc.20.2.177. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384323 Free PMC article.

138

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization.

Lee JE, Park JW, Lee IJ, Kim BH, Kim SH, Kim HB. Lee JE, et al. J Liver Cancer. 2020 Sep;20(2):154-159. doi: 10.17998/jlc.20.2.154. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384322 Free PMC article.

139

Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery.

Lim JY, Lee M, Kim TH. Lim JY, et al. J Liver Cancer. 2020 Sep;20(2):113-119. doi: 10.17998/jlc.20.2.113. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384321 Free PMC article. Review.

140

Prognostic Significance of Preoperative Controlling Nutritional Status Score in Patients Who Underwent Hepatic Resection for Hepatocellular Carcinoma.

Kim BS. Kim BS. J Liver Cancer. 2020 Sep;20(2):106-112. doi: 10.17998/jlc.20.2.106. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384320 Free PMC article. Review.

141

Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy.

Shin KI, Jang BK, Kim JH, Hwang JS. Shin KI, et al. J Liver Cancer. 2020 Sep;20(2):167-172. doi: 10.17998/jlc.20.2.167. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384319 Free PMC article.

142

Imaging Modalities for Hepatocellular Carcinoma Surveillance: Expanding Horizons beyond Ultrasound.

Park HJ, Kim SY. Park HJ, et al. J Liver Cancer. 2020 Sep;20(2):99-105. doi: 10.17998/jlc.20.2.99. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384318 Free PMC article. Review.

143

Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry.

Chon YE, Lee HA, Yoon JS, Park JY, Kim BH, Lee IJ, Hong SK, Lee DH, Kong HJ, Kim E, Won YJ, Lee JH. Chon YE, et al. J Liver Cancer. 2020 Sep;20(2):135-147. doi: 10.17998/jlc.20.2.135. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384317 Free PMC article.

144

Rare Clinical and Radiologic Case of Cholangiocarcinoma Mimicking Pyogenic Abscess, Hepatic Echinococcal Cysts, and Metastases.

Lee SH, Ryu SH, Lee DH, Yoon WE, Park TY, Lee HK, Moon JS. Lee SH, et al. J Liver Cancer. 2020 Sep;20(2):173-176. doi: 10.17998/jlc.20.2.173. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384316 Free PMC article.

145

Validation of the Korean Liver Cancer Association-National Cancer Center 2018 Criteria for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using Magnetic Resonance Imaging.

Lee S, Kim MJ. Lee S, et al. J Liver Cancer. 2020 Sep;20(2):120-127. doi: 10.17998/jlc.20.2.120. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384315 Free PMC article.

146

A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy.

Lee JY, Yoo JJ, Chun SJ, Bae SH, Lee JM, Kim SG, Kim YS. Lee JY, et al. J Liver Cancer. 2020 Mar;20(1):78-83. doi: 10.17998/jlc.20.1.78. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383060 Free PMC article.

147

Recurrent Coronary Artery Vasospasm in a Patient with Hepatocellular Carcinoma Treated with Sorafenib: a Case Report and Literature Review.

Lim DH, Yoon JH, Jun DW, Lee OY, Yoon BC, Lee HR, Kim KS, Choi HS. Lim DH, et al. J Liver Cancer. 2020 Mar;20(1):67-71. doi: 10.17998/jlc.20.1.67. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383059 Free PMC article.

148

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure.

Kim J, Chang JW, Park JY. Kim J, et al. J Liver Cancer. 2020 Mar;20(1):72-77. doi: 10.17998/jlc.20.1.72. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383058 Free PMC article.

149

Combined Transarterial Chemoembolization and External Beam Radiotherapy in a Patient with Recurrent Huge Hepatocellular Carcinoma after Hepatic Resection.

Yu J, Jung J, Yoon SM. Yu J, et al. J Liver Cancer. 2020 Mar;20(1):90-97. doi: 10.17998/jlc.20.1.90. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383057 Free PMC article.

150

Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma.

Yu SJ, Greten TF. Yu SJ, et al. J Liver Cancer. 2020 Mar;20(1):1-16. doi: 10.17998/jlc.20.1.1. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383056 Free PMC article. Review.

151

Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.

Kim S, Kim HY, Lee SL, Ku YM, Won YD, Kim CW. Kim S, et al. J Liver Cancer. 2020 Mar;20(1):60-66. doi: 10.17998/jlc.20.1.60. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383055 Free PMC article.

152

Liver Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance.

Park SH, Kim B. Park SH, et al. J Liver Cancer. 2020 Mar;20(1):25-31. doi: 10.17998/jlc.20.1.25. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383054 Free PMC article. Review.

153

Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma.

Seok J, Suk KT. Seok J, et al. J Liver Cancer. 2020 Mar;20(1):32-40. doi: 10.17998/jlc.20.1.32. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383053 Free PMC article.

154

Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry.

Yoon JS, Lee HA, Park JY, Kim BH, Lee IJ, Chon YE, Hong SK, Lee DH, Kong HJ, Won YJ, Kim E, Lee JH. Yoon JS, et al. J Liver Cancer. 2020 Mar;20(1):41-52. doi: 10.17998/jlc.20.1.41. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383052 Free PMC article.

155

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Lee SK, Jang JW, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK. Lee SK, et al. J Liver Cancer. 2020 Mar;20(1):84-89. doi: 10.17998/jlc.20.1.84. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383051 Free PMC article.

156

Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors.

Kim H, Jang M, Park YN. Kim H, et al. J Liver Cancer. 2020 Mar;20(1):17-24. doi: 10.17998/jlc.20.1.17. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383050 Free PMC article. Review.

157

A Survey of Liver Cancer Specialists' Views on the National Liver Cancer Screening Program in Korea.

Sohn W, Lee YS, Lee JG, An J, Jang ES, Lee DH, Sinn DH. Sohn W, et al. J Liver Cancer. 2020 Mar;20(1):53-59. doi: 10.17998/jlc.20.1.53. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year